Last reviewed · How we verify
NCT07172555
Virtual Dietetic Interventions in Patients With Coeliac
NA trial testing Virtual Dietetic First-Appointment Webinar for Coeliac Disease in Coeliac Disease in 60 participants. Currently enrolling.
15 June 2027
Quick facts
| Lead sponsor | Sheffield Teaching Hospitals NHS Foundation Trust |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 1 December 2025 |
| Primary completion | 15 June 2027 |
| Estimated completion | 15 June 2027 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Virtual Dietetic First-Appointment Webinar for Coeliac Disease
- Standard Dietetic Consultation (Face-to-Face or Telephone)
Conditions studied
- Coeliac Disease — all drugs for Coeliac Disease →
Sponsor
Sheffield Teaching Hospitals NHS Foundation Trust
Who can join
18 and older, any sex, with Coeliac Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This clinical study is exploring whether a pre-recorded, on-demand webinar led by specialist dietitians can be as effective as traditional one-on-one appointments in helping people newly diagnosed with coeliac disease learn to follow a gluten-free diet. Coeliac disease is a serious, life-long condition where eating even tiny amounts of gluten, a substance found in wheat, barley, and rye, can cause damaging symptoms and long-term health problems. The only current treatment is sticking to a strict gluten-free diet, which can be difficult without proper support and guidance from dietitians. The number of people being diagnosed with coeliac disease in the UK is growing, and this is placing extra pressure on NHS dietetic services, which are already stretched. Many patients currently face long waits or do not get any dietetic support at all. To address this, the research team at Sheffield Teaching Hospitals has developed an on-demand, first-appointment webinar to provide immediate access to trusted dietary information, with the aim of improving patient care and saving NHS resources. In this study, adults newly diagnosed with coeliac disease at Sheffield Teaching Hospitals will be asked to join one of two groups: one group will receive their first dietitian appointment through the new on-demand webinar, while the other group will have a traditional face-to-face or phone appointment with a dietitian. Both groups will complete short questionnaires to measure their knowledge about the gluten-free diet, their symptoms, how well they are following the diet, and their quality of life, both before and after receiving their dietary support, and again after six months. Blood tests will also be used to monitor health markers. The main goal of the research is to find out if the first-appointment webinar is just as effective as traditional appointments in helping patients understand and follow a gluten-free diet, feel satisfied with the support they receive, and achieve good health outcomes. If the study shows that the webinar approach is as good as traditional care, it could mean quicker, easier, and more consistent access to essential dietary support for people with coeliac disease, both locally and across the UK. Hypothesis: The study hypothesis is that a dietitian-led, on-demand, pre-recorded webinar for a first appointment is as effective as traditional one-to-one consultations (face-to-face or by phone) in helping newly diagnosed coeliac patients achieve the same standard health outcomes, dietary knowledge, and satisfaction with care.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07172555
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Coeliac Disease
Currently open trials in the same condition.
- NCT06557772 — A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac Disease · Phase 2 · active not recruiting
Other Sheffield Teaching Hospitals NHS Foundation Trust trials
Trials by the same sponsor.
- NCT07407712 — Better Outcomes Through Optimal Sleep in Surgical Training · NA · recruiting
- NCT06310993 — Exercise to Boost Immunity in Advanced Cancer · NA · not yet recruiting
- NCT06905405 — The Use of Advanced Imaging in HFpEF · recruiting
- NCT06633627 — Neurological Responses in Patients with Dentine Hypersensitivity · recruiting
- NCT07178041 — Remote Ischaemic Conditioning for Post-surgical Complications in Hip Fracture (RIC-FRACTURE) · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07172555 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sheffield Teaching Hospitals NHS Foundation Trust
- Last refreshed: 18 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07172555.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing